APLMW (Apollomics) FCF Margin %: 0.00% (As of Dec. 2025)


APLMW Apollomics Inc APLMW
31 GF Score
Price $0.01
! 5 Warning Signs
View Full Analysis

What is Apollomics FCF Margin %?

Apollomics APLMW -7.91% 31 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates APLMW with a GF Score™ of 31/100. The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, Apollomics ranks worse than 55.58% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Apollomics's Free Cash Flow for the six months ended in Dec. 2025 was $-2.75 Mil. Apollomics's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Apollomics's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Apollomics's current FCF Yield % is -6,819.37%.

The historical rank and industry rank for Apollomics's FCF Margin % or its related term are showing as below:


During the past 6 years, the highest FCF Margin % of Apollomics was -121.99%. The lowest was -121.99%. And the median was -121.99%.

APLMW's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Apollomics FCF Margin % Related Terms

Apollomics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Apollomics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollomics FCF Margin % Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -121.99

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -89.69 0.00

APLMW vs TVRD, PLRZ, LSTA: FCF Margin % Comparison

For the Biotechnology subindustry, Apollomics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollomics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apollomics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Apollomics's FCF Margin % falls into.


APLMW
31GF Score
Apollomics Inc APLMW
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apollomics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Apollomics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-10.369/8.5
=-121.99 %

Apollomics's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.745/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Apollomics (APLMW) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Apollomics and its competitors. According to the industry distribution chart, Apollomics ranks #533 out of 959 companies in the Biotechnology industry, placing it in the top 55.6%.
Is Apollomics' FCF Margin % too high?
Apollomics' current FCF Margin % is 0.00%. Based on the distribution chart, Apollomics ranks #533 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Apollomics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Apollomics' FCF Margin % compare to TVRD and PLRZ?
According to the Biotechnology industry distribution chart, Apollomics ranks #533 out of 959 companies for FCF Margin %. This places Apollomics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Apollomics and its competitors. Apollomics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollomics stock overvalued right now?
Apollomics (APLMW) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Apollomics' overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Apollomics (APLMW), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apollomics Business Description

Other Exchanges APLM:USA
Address 989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.
31GF Score

Get the complete analysis for APLMW

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price